ArticleJournal of biomedical science2021

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

Tong-Tong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.